Related Experiment Videos
A randomized, controlled study of a mandibular advancement splint for obstructive sleep apnea
1Centre for Sleep Disorders and Respiratory Failure, Department of Respiratory Medicine, St George Hospital, University of New South Wales, UK.
Summary
A novel mandibular advancement splint (MAS) effectively treats obstructive sleep apnea (OSA). This oral appliance significantly reduced the Apnea/Hypopnea Index (AHI) and improved sleep quality in patients with moderate to severe OSA.
Area of Science:
- Sleep Medicine
- Medical Devices
Background:
- Obstructive sleep apnea (OSA) is a growing concern with limited evidence for oral appliance efficacy.
- The exact mechanisms of action for oral appliances in OSA treatment remain unclear.
Purpose of the Study:
- To systematically investigate the efficacy of a novel mandibular advancement splint (MAS) in patients diagnosed with OSA.
- To evaluate the impact of MAS on key sleep apnea metrics and patient-reported outcomes.
Main Methods:
- A randomized, controlled three-period crossover study involving 28 patients with proven OSA.
- Polysomnography was conducted with a control oral plate (no mandibular advancement) and the MAS.
- Complete response (CR) defined as symptom resolution and Apnea/Hypopnea Index (AHI) < 5/h; partial response (PR) as >50% AHI reduction.
Main Results:
- The MAS significantly improved AHI (30/h to 14/h), minimum oxygen saturation (MinSa(O2)) (87% to 91%), and arousal index (41/h to 27/h) compared to the control (p < 0.0001).
- 96% of patients reported subjective improvements with the MAS.
- 62.5% of patients achieved either CR (n=9) or PR (n=6), including those with moderate or severe OSA.
Conclusions:
- The novel mandibular advancement splint (MAS) demonstrates significant efficacy in treating obstructive sleep apnea (OSA).
- MAS provides a viable treatment option for patients with moderate to severe OSA, improving key sleep metrics and subjective well-being.